Analyst Reco. Sanofi

Equities

Market Closed - Euronext Paris Other stock markets 16:55:00 15/12/2025 GMT			5-day change	1st Jan Change
80.60 ^EUR	-3.26%		-3.59%	-14.02%

12:00am	South Korea's ADEL signs up to $1.04 billion Alzheimer's drug development deal with Sanofi	RE
12-15	Health Care Up on Defensive Bias -- Health Care Roundup	DJ

Sanofi Kept at Buy as BofA Notes Sanofi's Multiple Sclerosis Drug Setbacks, 'Very Light' FY26 Catalysts	12-15	MT
Bank of America Maintains Sanofi at Buy	12-15	MT
SANOFI : Goldman Sachs is Neutral	12-15	ZD
SANOFI : UBS maintains a Buy rating	12-15	ZD
SANOFI : Gets a Buy rating from Barclays	12-15	ZD
SANOFI : Jefferies reaffirms its Buy rating	12-15	ZD
SANOFI : JP Morgan reiterates its Neutral rating	12-15	ZD
Guggenheim Downgrades Sanofi to Neutral From Buy	12-09	MT
SANOFI : JP Morgan is Neutral	12-08	ZD
SANOFI : Buy rating from Bernstein	12-05	ZD
SANOFI : Deutsche Bank reiterates its Buy rating	11-25	ZD
SANOFI : Buy rating from Jefferies	11-19	ZD
Sanofi Announces Positive Results from the pivotal LIBERTY- AFRS-AIMS Phase 3 Study	11-07	CI
Regeneron, Sanofi Say Dupixent for Allergic Fungal Rhinosinusitis Met Primary Endpoint in Phase 3 Study	11-07	MT
Sanofi, Regeneron's Dupixent Hits Key Goals in Late-Stage Fungal Allergy Trial	11-07	DJ
Sanofi's Dupixent Achieves Phase 3 Success in Allergic Fungal Rhinosinusitis	11-07
Sanofi and Regeneron's Dupixent meets endpoints, accepted for priority review by FDA	11-07	RE
Berenberg Upbeat on Sanofi's Top Line Growth, R&D Turnaround	11-07	MT
SANOFI : Deutsche Bank reaffirms its Buy rating	10-30	ZD
SANOFI : Goldman Sachs gives a Neutral rating	10-28	ZD
SANOFI : Deutsche Bank gives a Buy rating	10-27	ZD
UBS remains bullish on Sanofi after quarterly results.	10-27
SANOFI : Receives a Buy rating from Jefferies	10-27	ZD
SANOFI : UBS reiterates its Buy rating	10-27	ZD
SANOFI : DZ Bank keeps its Buy rating	10-24	ZD